Growing older is a natural part of life, but scientists around the world are searching for ways to help people stay healthier for longer. As life expectancy rises, more people are living into their seventies, eighties, and beyond.
However, longer lives often come with age-related diseases such as heart disease, dementia, diabetes, and frailty. Researchers are increasingly focusing not only on extending lifespan but also on improving healthspan, which means the number of years people remain healthy and active.
One of the most exciting ideas in aging research is that it may be possible to slow down some of the biological processes that drive aging. If scientists can find safe ways to delay aging, they may also be able to delay the development of many age-related diseases at the same time.
Now, a new study suggests that a well-known blood pressure medication may have surprising anti-aging properties.
The drug, called rilmenidine, has been prescribed for years to treat high blood pressure. It is generally considered safe and has relatively few side effects. Researchers now believe it could potentially do much more than control blood pressure.
The study was published in the journal Aging Cell and was led by Professor João Pedro Magalhães, who began the research at the University of Liverpool and now continues his work at the University of Birmingham.
To investigate whether rilmenidine could influence aging, the researchers used tiny roundworms known as C. elegans. Although these worms may seem very different from humans, they are widely used in aging research because they have short lifespans and share many important biological pathways with people.
Their brief lives allow scientists to observe the effects of treatments on aging much more quickly than would be possible in humans.
The results were encouraging. The worms that received rilmenidine lived longer and remained healthier than untreated worms. The treated worms showed improvements that resembled the effects seen in animals that consume fewer calories.
Scientists have long known that calorie restriction can extend lifespan in many different species. Studies in worms, flies, mice, and other animals have shown that eating fewer calories while still receiving adequate nutrition can slow aging and improve health.
However, maintaining a long-term calorie-restricted diet is extremely difficult for most people. Such diets can also cause side effects and may not be practical or safe for everyone.
Because of these challenges, researchers have been searching for medications that can mimic the benefits of calorie restriction without requiring people to eat substantially less food. These treatments are sometimes called calorie restriction mimetics.
The researchers discovered that rilmenidine appears to work through a specific receptor called the I1-imidazoline receptor, also known as nish-1.
This receptor seems to play an important role in the biological pathways that affect health and lifespan. By activating this receptor, rilmenidine may trigger some of the same protective mechanisms that are switched on during calorie restriction.
The findings are exciting because rilmenidine already has an important advantage over many experimental anti-aging drugs. Since it is already widely used to treat high blood pressure, doctors have years of experience with its safety profile.
This could potentially allow researchers to move more quickly toward human studies compared with entirely new drugs that have never been tested in people.
The study also highlights an important public health issue. Populations around the world are aging rapidly. Even small delays in the aging process could produce major benefits for society by reducing illness, preserving independence, and lowering healthcare costs.
However, researchers caution that the findings are still at an early stage. The study was performed in worms, not humans. Scientists still need to determine whether rilmenidine can safely slow aging in people and whether its benefits extend beyond blood pressure control.
The next steps will involve studying the drug’s effects in more complex animal models and eventually conducting clinical trials in humans. Researchers also want to understand whether rilmenidine influences other aspects of aging and whether it can help prevent age-related diseases.
Although much work remains to be done, the discovery offers an intriguing possibility. A familiar and relatively safe medication that has been used for years to treat high blood pressure could one day become part of a new generation of therapies designed to help people live not only longer lives but also healthier ones.
If you care about high blood pressure, please read studies that early time-restricted eating could help improve blood pressure, and natural coconut sugar could help reduce blood pressure and artery stiffness.
For more health information, please see recent studies about added sugar in your diet linked to higher blood pressure, and results showing vitamin D could improve blood pressure in people with diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
